PRESENTED BY NIMITT CONSULTING
The Cell Therapy Master Class on Access & Reimbursement
An intensive, two-day hospital-focused event designed for the teams that power cell therapy programs.
October 28–29, 2026
In-person in Washington, D.C.
Register NowWhy This, Why Now:
Hear directly from the Nimitt team about why this Master Class was created, who it is built for, and why providers should attend.
Event Details
Presented by
Nimitt Consulting Inc.
Dates
October 28–29, 2026
Location
Washington, D.C.
Event space graciously provided by:
Hogan Lovells
555 13th Street, NW
Washington, DC 20004
Pricing
Early Bird Pricing
$1,475
per attendee through 5/31/2026
Standard Pricing
$1,875
per attendee effective 6/01/2026
Fees cover:
- All workshop materials & practical take-home tools and templates
- Breakfast and lunch
- Networking cocktail reception
Multiple-attendee discounts are available. Contact us for pricing information and a promo code.
Hotel Suggestions
These suggestions are provided for your convenience.
Turning Breakthrough Science into Real-World Patient Access
Cellular therapies represent hope, progress, and a new era of possibility for patients, but transforming breakthrough science into real-world patient access requires more than clinical innovation—it demands mastery of financial clearance, coding, billing, reimbursement, and Managed Care strategy.
To help cell therapy programs rise to this challenge, Nimitt Consulting will debut an intensive two-day Master Class, built exclusively for hospital and program administrators, Managed Care professionals, finance teams, and those involved in delivering cell therapies.
Grounded in Nimitt’s mission to be a catalyst for change, this Master Class will go far beyond a traditional conference. Participants will experience a structured, hands-on learning experience that will engage, educate, and empower them through:
- Examples drawn from real-world experiences
- Interactive problem-solving exercises
- Small-group discussions
- Practical take-home tools and templates
Attendees will leave the Master Class with a clear and actionable roadmap to support patient access, strengthen financial program performance, and confidently navigate the rapidly evolving cell therapy landscape.
This is a Master Class for those who wonder:
- How can we optimize our financial clearance process?
- What are best practices when it comes to onboarding new therapies?
- What codes should be reported—and when?
- Where do gaps or inefficiencies most frequently occur in our cell therapy programs?
- Why does pricing matter, and how does it affect downstream reimbursement?
- How do we financially model something we’ve never done before?
- How do we develop contracts with commercial payers?
- Why do denials occur and how can we prevent them?
- How should our services be paid?